Difficulty: Medium
Average Score: 74%
Practice
Which of the following cholinesterase inhibitors is irreversible?
Correct answer
D
Rationale
In pharmacology, cholinesterase inhibitors are classified as reversible or irreversible based on their mechanism of action. In this case, the correct answer is D) Isoflurophate because it is an irreversible cholinesterase inhibitor.
Irreversible cholinesterase inhibitors form a strong covalent bond with the enzyme acetylcholinesterase, leading to a long-lasting inhibition of the enzyme's activity. This results in an accumulation of acetylcholine at cholinergic synapses, prolonging its action.
Physostigmine (A), Edrophonium (B), and Neostigmine (C) are all reversible cholinesterase inhibitors. They form weaker, reversible bonds with acetylcholinesterase, allowing the enzyme to recover its activity over time.
Understanding the distinction between reversible and irreversible cholinesterase inhibitors is crucial in pharmacology, especially in the context of treating conditions like myasthenia gravis or reversing neuromuscular blockade. Practitioners must be aware of the differences in potency, duration of action, and potential side effects associated with each type of inhibitor to make informed clinical decisions.
Irreversible cholinesterase inhibitors form a strong covalent bond with the enzyme acetylcholinesterase, leading to a long-lasting inhibition of the enzyme's activity. This results in an accumulation of acetylcholine at cholinergic synapses, prolonging its action.
Physostigmine (A), Edrophonium (B), and Neostigmine (C) are all reversible cholinesterase inhibitors. They form weaker, reversible bonds with acetylcholinesterase, allowing the enzyme to recover its activity over time.
Understanding the distinction between reversible and irreversible cholinesterase inhibitors is crucial in pharmacology, especially in the context of treating conditions like myasthenia gravis or reversing neuromuscular blockade. Practitioners must be aware of the differences in potency, duration of action, and potential side effects associated with each type of inhibitor to make informed clinical decisions.